Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DETERMINATION OF THE DOSE AND EFFECTIVENESS OF CONVALESCENT PLASMA IN SEVERELY AND VERY SEVERELY ILL PATIENTS BY COVID-19

NCT04356482 is registered in ClinicalTrials.gov with Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado as lead sponsor.

NCT NCT04356482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04356482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DETERMINATION OF THE DOSE AND EFFECTIVENESS OF CONVALESCENT PLASMA IN SEVERELY AND VERY SEVERELY ILL PATIENTS BY COVID-19
Lead sponsor
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
Phase
Phase 1/2
Overall status
Unknown status
Start date
May 20, 2020
Completion date
December 31, 2020
Enrollment
90 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

convalescence, covid-19, doses, plasma, sars-cov 2